BAX insiders

26 insiders have filed at BAX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Hider Andrew P.President And CEO572.2k0.111%
Almeida Jose EChairman, CEO, President568.6k0.11%
Grade Joel T.EVP And CFO271.7k0.053%
Mason Jeanne KEVP, Chief Hr Officer199.9k0.039%1 sells $2.6M
Knight HeatherEVP, Chief Operating Officer177.4k0.034%
Rosenbloom David S.EVP And General Counsel138.2k0.027%
Sonig AlokEVP,group President,pharma128.2k0.025%
Rasul ReazurEVP,group Pres,healthcare125.6k0.024%
Toth Christopher A.EVP, Group Pres, Kidney Care105.2k0.02%
Soriano Maria CeciliaGroup Pres., Itt & Pharma.75.0k0.015%
Borzi James WEVP,chief Supply Chain Officer71.9k0.014%
Stevens BrianSVP, CAO & Controller67.5k0.013%
Shafer David BrentDirector59.4k0.012%
Zielinski Anita ASVP, CAO And Controller46.3k<0.01%
Oesterle Stephen N.Director35.8k<0.01%
Wendell Amy McbrideDirector31.2k<0.01%
Smith Cathy RDirector30.3k<0.01%
Morrison PatriciaDirector29.1k<0.01%
Wilkes David S.Director23.9k<0.01%
Schlichting Nancy MDirector21.9k<0.01%
Ampofo William A. IIDirector17.3k<0.01%
Rusckowski Stephen HDirector16.5k<0.01%
Wilver Peter MDirector13.3k<0.01%
Craig Jeffrey ADirector10.7k<0.01%
Carlisle CynthiaExecutive Vice President, Chro
Mcdonnell Michael R.Director

Full register at boothcheck.com/insiders/BAX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

BAX institutional holders · BAX research report